1. | gipsyrose85 | |
2. | sneekygit | |
3. | jojo499009 |
1. | gipsyrose85 | |
2. | sneekygit | |
3. | jojo499009 |
1. | jojo499009 07/12/2018 resTORbio Announces Science Translational Medicine Publication of Phase 2a Data Showing Improvement in Immune Function and Decreased Infection Rates in People Aged 65 Years and Older |
2. | sneekygit 01/25/2018 Company has priced 5.67mm shares at a mid-range price of $15.00 |
3. | gipsyrose85 07/25/2018 Announces 'positive' topline results from its dose-ranging Phase 2b clinical trial |
4. | gipsyrose85 03/30/2018 resTORbio Reports Fourth Quarter and Full Year 2017 Financial Results |